AIM
AIM ImmunoTech
32 hedge funds and large institutions have $5.88M invested in AIM ImmunoTech in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$708K | |
| 2 | +$251K | |
| 3 | +$206K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$143K |
| 5 |
BCM
Bayesian Capital Management
Brooklyn,
New York
|
+$91K |
Top Sellers
| 1 | -$80K | |
| 2 | -$72K | |
| 3 | -$63K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$44K |
| 5 |
MFG
Magnus Financial Group
New York
|
-$35K |